The perfusion systems market size has grown rapidly in recent years. It will grow from $1.45 billion in 2025 to $1.6 billion in 2026 at a compound annual growth rate (CAGR) of 10.4%. The growth in the historic period can be attributed to growth in complex cardiac surgical procedures, increasing number of organ transplantation surgeries, expansion of extracorporeal life support programs, rising adoption of cardiopulmonary bypass systems, improvements in critical care infrastructure.
The perfusion systems market size is expected to see rapid growth in the next few years. It will grow to $2.38 billion in 2030 at a compound annual growth rate (CAGR) of 10.5%. The growth in the forecast period can be attributed to increasing investments in advanced surgical care facilities, rising demand for portable and modular perfusion systems, expansion of organ preservation applications, growing focus on patient safety and outcome optimization, continued innovation in perfusion device automation. Major trends in the forecast period include increasing adoption of advanced ecmo platforms, rising use of normothermic perfusion techniques, growing integration of perfusion monitoring systems, expansion of portable perfusion solutions, enhanced focus on organ preservation technologies.
The rising number of organ transplants is expected to drive the growth of the perfusion systems market. Organ transplants are surgical procedures in which a diseased or damaged organ is removed from a donor and transplanted into a recipient who requires it due to organ failure or disease. Perfusion systems are critical for preserving and transporting organs during transplantation, ensuring their viability. For instance, in January 2024, according to the Organ Procurement and Transplantation Network (OPTN), a US-based federally authorized system for organ transplant allocation, 46,632 organ transplants were performed in the United States in 2023, representing an 8.7% increase from 2022. Therefore, the increase in organ transplants is fueling demand for perfusion systems.
Major companies operating in the perfusion systems market are concentrating on the development of innovative products, such as the Essenz patient monitor, to improve clinical efficiency and patient care during cardiopulmonary bypass procedures. This advanced monitoring system includes a centralized display that continuously presents patient parameters, enabling customized patient management approaches. For example, in February 2023, LivaNova, a UK-based provider of neuromodulation devices and cardiopulmonary products, introduced the Essenz perfusion system in Europe. The Essenz system is a compact, modular, and portable cardiopulmonary bypass (CPB) system designed for use in cardiac surgeries. Its modular configuration allows customization based on the specific requirements of individual patients and surgical procedures. Additionally, the system’s compact and portable design supports easy transportation and setup across a range of clinical environments.
In September 2024, Getinge, a Sweden-based provider of hospital and life-science equipment, acquired Paragonix Technologies for $477 million. This acquisition aims to expand Getinge’s presence in the growing organ preservation and transport market by integrating Paragonix’s advanced organ transport and perfusion technologies into its global commercial network. Paragonix Technologies is a US-based developer of perfusion systems for donor organ preservation and transport.
Major companies operating in the perfusion systems market are Getinge AB, Medtronic plc, LivaNova PLC, Terumo Corporation, Lifeline Scientific Inc., XVIVO Perfusion AB, XENIOS AG, Sorin Group, Organ Assist Products B.V., Organ Recovery Systems Inc., TransMedics Inc., Paragonix Technologies Inc., Bridge to Life Europe Ltd., OrganOx Limited, Preservation Solutions Inc., Repligen Corporation, Spectrum Laboratories Inc., Harvard Bioscience Inc., ALA Scientific Instruments Inc., Bioptechs Inc., Cytiva.
North America was the largest region in the perfusion systems market in 2025. The regions covered in the perfusion systems market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the perfusion systems market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the perfusion systems market by increasing costs of imported pumps, oxygenators, heat exchangers, sensors, and electronic control units used across cardiopulmonary bypass and ECMO systems. Cardiac surgery centers and transplant hospitals in North America and Europe are most affected due to reliance on imported high-precision components, while Asia-Pacific faces increased system costs for advanced perfusion platforms. These tariffs are elevating capital expenditure requirements and affecting equipment upgrade cycles. However, they are also driving domestic manufacturing initiatives, regional assembly of perfusion systems, and investment in local engineering capabilities to strengthen supply resilience.
The perfusion systems market research report is one of a series of new reports that provides perfusion systems market statistics, including perfusion systems industry global market size, regional shares, competitors with a perfusion systems market share, detailed perfusion systems market segments, market trends and opportunities, and any further data you may need to thrive in the perfusion systems industry. This perfusion systems market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Perfusion systems encompass vital medical devices employed to sustain blood circulation and oxygenation in patients during surgical procedures necessitating a temporary pause in the heart's normal function. Primarily utilized in cardiac surgeries, organ transplants, and other procedures requiring temporary organ function support, these systems play a critical role in maintaining physiological stability.
They come in various types, including cardiopulmonary perfusion systems, extracorporeal membrane oxygenation (ECMO), isolated organ perfusion systems, and specialized variations. Cardiopulmonary perfusion systems specifically substitute the heart and lung functions temporarily during cardiac surgeries. These systems cater to diverse organs such as the heart, lungs, kidneys, liver, and others, employing techniques such as hypothermic and normothermic approaches. Their applications span across different healthcare settings, including hospitals, clinics, ambulatory surgical centers, and various other medical facilities.
The perfusion systems market consists of revenues earned by entities by providing organ transplantation service, blood management services, cell isolation care, cardiac and respiratory disorders surgery services. The market value includes the value of related goods sold by the service provider or included within the service offering. The perfusion systems market also includes sales of oxygenators, tubing, and filters equipment which are used in providing perfusion systems related services. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The perfusion systems market size is expected to see rapid growth in the next few years. It will grow to $2.38 billion in 2030 at a compound annual growth rate (CAGR) of 10.5%. The growth in the forecast period can be attributed to increasing investments in advanced surgical care facilities, rising demand for portable and modular perfusion systems, expansion of organ preservation applications, growing focus on patient safety and outcome optimization, continued innovation in perfusion device automation. Major trends in the forecast period include increasing adoption of advanced ecmo platforms, rising use of normothermic perfusion techniques, growing integration of perfusion monitoring systems, expansion of portable perfusion solutions, enhanced focus on organ preservation technologies.
The rising number of organ transplants is expected to drive the growth of the perfusion systems market. Organ transplants are surgical procedures in which a diseased or damaged organ is removed from a donor and transplanted into a recipient who requires it due to organ failure or disease. Perfusion systems are critical for preserving and transporting organs during transplantation, ensuring their viability. For instance, in January 2024, according to the Organ Procurement and Transplantation Network (OPTN), a US-based federally authorized system for organ transplant allocation, 46,632 organ transplants were performed in the United States in 2023, representing an 8.7% increase from 2022. Therefore, the increase in organ transplants is fueling demand for perfusion systems.
Major companies operating in the perfusion systems market are concentrating on the development of innovative products, such as the Essenz patient monitor, to improve clinical efficiency and patient care during cardiopulmonary bypass procedures. This advanced monitoring system includes a centralized display that continuously presents patient parameters, enabling customized patient management approaches. For example, in February 2023, LivaNova, a UK-based provider of neuromodulation devices and cardiopulmonary products, introduced the Essenz perfusion system in Europe. The Essenz system is a compact, modular, and portable cardiopulmonary bypass (CPB) system designed for use in cardiac surgeries. Its modular configuration allows customization based on the specific requirements of individual patients and surgical procedures. Additionally, the system’s compact and portable design supports easy transportation and setup across a range of clinical environments.
In September 2024, Getinge, a Sweden-based provider of hospital and life-science equipment, acquired Paragonix Technologies for $477 million. This acquisition aims to expand Getinge’s presence in the growing organ preservation and transport market by integrating Paragonix’s advanced organ transport and perfusion technologies into its global commercial network. Paragonix Technologies is a US-based developer of perfusion systems for donor organ preservation and transport.
Major companies operating in the perfusion systems market are Getinge AB, Medtronic plc, LivaNova PLC, Terumo Corporation, Lifeline Scientific Inc., XVIVO Perfusion AB, XENIOS AG, Sorin Group, Organ Assist Products B.V., Organ Recovery Systems Inc., TransMedics Inc., Paragonix Technologies Inc., Bridge to Life Europe Ltd., OrganOx Limited, Preservation Solutions Inc., Repligen Corporation, Spectrum Laboratories Inc., Harvard Bioscience Inc., ALA Scientific Instruments Inc., Bioptechs Inc., Cytiva.
North America was the largest region in the perfusion systems market in 2025. The regions covered in the perfusion systems market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the perfusion systems market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the perfusion systems market by increasing costs of imported pumps, oxygenators, heat exchangers, sensors, and electronic control units used across cardiopulmonary bypass and ECMO systems. Cardiac surgery centers and transplant hospitals in North America and Europe are most affected due to reliance on imported high-precision components, while Asia-Pacific faces increased system costs for advanced perfusion platforms. These tariffs are elevating capital expenditure requirements and affecting equipment upgrade cycles. However, they are also driving domestic manufacturing initiatives, regional assembly of perfusion systems, and investment in local engineering capabilities to strengthen supply resilience.
The perfusion systems market research report is one of a series of new reports that provides perfusion systems market statistics, including perfusion systems industry global market size, regional shares, competitors with a perfusion systems market share, detailed perfusion systems market segments, market trends and opportunities, and any further data you may need to thrive in the perfusion systems industry. This perfusion systems market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Perfusion systems encompass vital medical devices employed to sustain blood circulation and oxygenation in patients during surgical procedures necessitating a temporary pause in the heart's normal function. Primarily utilized in cardiac surgeries, organ transplants, and other procedures requiring temporary organ function support, these systems play a critical role in maintaining physiological stability.
They come in various types, including cardiopulmonary perfusion systems, extracorporeal membrane oxygenation (ECMO), isolated organ perfusion systems, and specialized variations. Cardiopulmonary perfusion systems specifically substitute the heart and lung functions temporarily during cardiac surgeries. These systems cater to diverse organs such as the heart, lungs, kidneys, liver, and others, employing techniques such as hypothermic and normothermic approaches. Their applications span across different healthcare settings, including hospitals, clinics, ambulatory surgical centers, and various other medical facilities.
The perfusion systems market consists of revenues earned by entities by providing organ transplantation service, blood management services, cell isolation care, cardiac and respiratory disorders surgery services. The market value includes the value of related goods sold by the service provider or included within the service offering. The perfusion systems market also includes sales of oxygenators, tubing, and filters equipment which are used in providing perfusion systems related services. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Perfusion Systems Market Characteristics
3. Perfusion Systems Market Supply Chain Analysis
4. Global Perfusion Systems Market Trends and Strategies
5. Perfusion Systems Market Analysis of End Use Industries
7. Global Perfusion Systems Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Perfusion Systems Total Addressable Market (TAM) Analysis for the Market
9. Perfusion Systems Market Segmentation
10. Perfusion Systems Market Regional and Country Analysis
11. Asia-Pacific Perfusion Systems Market
12. China Perfusion Systems Market
13. India Perfusion Systems Market
14. Japan Perfusion Systems Market
15. Australia Perfusion Systems Market
16. Indonesia Perfusion Systems Market
17. South Korea Perfusion Systems Market
18. Taiwan Perfusion Systems Market
19. South East Asia Perfusion Systems Market
20. Western Europe Perfusion Systems Market
21. UK Perfusion Systems Market
22. Germany Perfusion Systems Market
23. France Perfusion Systems Market
24. Italy Perfusion Systems Market
25. Spain Perfusion Systems Market
26. Eastern Europe Perfusion Systems Market
27. Russia Perfusion Systems Market
28. North America Perfusion Systems Market
29. USA Perfusion Systems Market
30. Canada Perfusion Systems Market
31. South America Perfusion Systems Market
32. Brazil Perfusion Systems Market
33. Middle East Perfusion Systems Market
34. Africa Perfusion Systems Market
36. Perfusion Systems Market Competitive Landscape and Company Profiles
37. Perfusion Systems Market Other Major and Innovative Companies
40. Perfusion Systems Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Perfusion Systems Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses perfusion systems market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for perfusion systems? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The perfusion systems market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product: Cardiopulmonary Perfusion System; Extracorporeal membrane oxygenation (ECMO); Isolated Organ Perfusion Systems2) By Type Of Organ: Heart; Lung; Kidney; Liver; Other Type Of Organs
3) By Technique: Hypothermic; Normothermic
4) By End-User: Hospital; Clinic
Subsegments:
1) By Cardiopulmonary Perfusion System: Heart-Lung Machines; Blood Pumps; Oxygenators2) By Extracorporeal Membrane Oxygenation (ECMO): Veno-Arterial (VA) ECMO Systems; Veno-Venous (VV) ECMO Systems; Portable ECMO Systems
3) By Isolated Organ Perfusion Systems: Liver Perfusion Systems; Kidney Perfusion Systems; Heart Perfusion Systems
Companies Mentioned: Getinge AB; Medtronic plc; LivaNova PLC; Terumo Corporation; Lifeline Scientific Inc.; XVIVO Perfusion AB; XENIOS AG; Sorin Group; Organ Assist Products B.V.; Organ Recovery Systems Inc.; TransMedics Inc.; Paragonix Technologies Inc.; Bridge to Life Europe Ltd.; OrganOx Limited; Preservation Solutions Inc.; Repligen Corporation; Spectrum Laboratories Inc.; Harvard Bioscience Inc.; ALA Scientific Instruments Inc.; Bioptechs Inc.; Cytiva
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Perfusion Systems market report include:- Getinge AB
- Medtronic plc
- LivaNova PLC
- Terumo Corporation
- Lifeline Scientific Inc.
- XVIVO Perfusion AB
- XENIOS AG
- Sorin Group
- Organ Assist Products B.V.
- Organ Recovery Systems Inc.
- TransMedics Inc.
- Paragonix Technologies Inc.
- Bridge to Life Europe Ltd.
- OrganOx Limited
- Preservation Solutions Inc.
- Repligen Corporation
- Spectrum Laboratories Inc.
- Harvard Bioscience Inc.
- ALA Scientific Instruments Inc.
- Bioptechs Inc.
- Cytiva
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 1.6 Billion |
| Forecasted Market Value ( USD | $ 2.38 Billion |
| Compound Annual Growth Rate | 10.5% |
| Regions Covered | Global |
| No. of Companies Mentioned | 22 |
